Consolidated figures
| Ratio | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Margins | ||||
| Gross margin % | — | — | — | — |
| EBITDA margin % | 17.1% | 18.5% | ||
| 15.8% |
| 13.8% |
| EBIT margin % | 14.8% | 15.9% | 12.9% | 10.6% |
| PAT margin % | 14% | 14.4% | 13.2% | 9.1% |
| Working capital | ||||
| Receivable days | 537 | 867 | 853 | 724 |
| Inventory days | 0 | 0 | 0 | 0 |
| Payable days | 746 | 1,159 | 1,079 | 858 |
| NWC days | -209 | -293 | -225 | -133 |
| Leverage | ||||
| Current ratio | 1.12 | 1.1 | 1.2 | 1.08 |
| Debt to EBITDA | 0.03 | 0.52 | 0.5 | 1.75 |
| Debt to equity | 0.02 | 0.25 | 0.11 | 0.42 |
| Interest coverage | 24.9 | 23 | 12.2 | 7.7 |
| Asset turnover | 0.42 | 0.29 | 0.28 | 0.29 |
| Return ratios | ||||
| Return on assets % | 5.8% | 4.1% | 3.7% | 2.6% |
| Return on capital employed % | 43.2% | 40.3% | 26.2% | 18.5% |
| Return on equity % | 43.6% | 36.8% | 19.2% | 15.8% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.